References
- Kim KW, Park JH, Kim MH, Kim MD, Kim BJ, Kim SG, et al. A nationwide survey on the prevalence of dementia and mild cognitive impairment(MCI) in South Korea. J Alzheimers Dis(in press).
- Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308. https://doi.org/10.1001/archneur.56.3.303
- Mubumbila V, Sutter A, Ptok U, Heun R, Quirin-Stricker C. Identification of a single nucleotide polymorphism in the choline acetyltransferase gene associated with Alzheimer's disease. Neurosci Lett 2002;333:9-12. https://doi.org/10.1016/S0304-3940(02)00955-2
- Kim KW, Suh YJ, Park WY, Jhoo JH, Lee DY, Youn JC, et al. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4. Neurosci Lett 2004;366:182-186. https://doi.org/10.1016/j.neulet.2004.05.041
- Ahn Jo S, Ahn K, Kim JH, Kang BH, Kim E, Jo I, et al. ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms(2384G>A and 1882G>A) with Alzheimer's disease. Clin Chim Acta 2006;368:179-182. https://doi.org/10.1016/j.cca.2005.12.037
- Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976;2:1403.
- Perry EK, Perry RH, Blessed G, Tomlinson BE. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977;1:189.
- Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978;2:1457-1459. https://doi.org/10.1136/bmj.2.6150.1457
- Davies P. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 1979;171:319-327. https://doi.org/10.1016/0006-8993(79)90336-6
- Wilcock GK, Esiri MM, Bowen DM, Smith CC. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 1982;57:407-417. https://doi.org/10.1016/0022-510X(82)90045-4
- Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 1995;64:749-760.
- DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145-155. https://doi.org/10.1002/ana.10069
- Tang M, Rao D, Ma C, Guo Y, Han H, Ling K, et al. Evaluation of choline acetyltransferase gene polymorphism( 2384 G/A) in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 2008;26:9-14. https://doi.org/10.1159/000140612
- Park JH, Lim S, Lim JY, Han MK, Yoon IY, Kim JM, et al. An overview of the Korean longitudinal study on health and aging. Pschiatry Invest 2007;4:84-95.
- Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-194. https://doi.org/10.1111/j.1365-2796.2004.01388.x
- Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, et al. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet(CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:P47-P53. https://doi.org/10.1093/geronb/57.1.P47
- Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview(M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22-33; quiz 34-57.
- Yoo SW, Kim YS, Noh JS, Oh KS, Kim CH, Nam KK, et al. Validity of Korean Version of the Mini-international Neuropsychiatric interview. Anxiety Mood 2006;2:50-55.
- Ruff RM, Light RH, Parker SB, Levin HS. Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol 1996;11:329-338. https://doi.org/10.1093/arclin/11.4.329
- Wechsler D. Wechsler Adult Intelligence Scale-administration and scoring manual. 3rd ed. San Antonio, TX: The Psychological Corporation;1997.
- Kim KW, Jhoo JH, Lee KU, Lee DY, Lee JH, Youn JY, et al. Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans. Neurosci Lett 1999;277:145-148. https://doi.org/10.1016/S0304-3940(99)00867-8
- Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69:138-147. https://doi.org/10.1086/321276
- Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003;19:376-382. https://doi.org/10.1093/bioinformatics/btf869
- Harold D, Peirce T, Moskvina V, Myers A, Jones S, Hollingworth P, et al. Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Hum Genet 2003;113:258-267. https://doi.org/10.1007/s00439-003-0960-2
- Schwarz S, Eisele T, Diehl J, Muller U, Forstl H, Kurz A, et al. Lack of association between a single nucleotide polymorphism within the choline acetyltransferase gene and patients with Alzheimer's disease. Neurosci Lett 2003;343:167-170. https://doi.org/10.1016/S0304-3940(03)00380-X
- Cook LJ, Ho LW, Wang L, Terrenoire E, Brayne C, Evans JG, et al. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. Am J Med Genet B Neuropsychiatr Genet 2005;132:5-8.
- Ozturk A, DeKosky ST, Kamboh MI. Genetic variation in the choline acetyltransferase(CHAT) gene may be associated with the risk of Alzheimer's disease. Neurobiol Aging 2006;27:1440-1444. https://doi.org/10.1016/j.neurobiolaging.2005.08.024
- Grunblatt E, Zehetmayer S, Bartl J, Loffler C, Wichart I, Rainer MK, et al. Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study. J Psychiatr Res 2009;43:298-308. https://doi.org/10.1016/j.jpsychires.2008.05.008
- Kozak M. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J 1997;16:2482-2492. https://doi.org/10.1093/emboj/16.9.2482
- Cohen EL, Wurtman RJ. Brain acetylcholine: increase after systemic choline administration. Life Sci 1975;16:1095-1102. https://doi.org/10.1016/0024-3205(75)90194-0
- Haubrich DR, Chippendale TJ. Regulation of acetylcholine synthesis in nervous tissue. Life Sci 1977;20:1465-1478. https://doi.org/10.1016/0024-3205(77)90437-4
- Baskin DS, Browning JL, Pirozzolo FJ, Korporaal S, Baskin JA, Appel SH. Brain choline acetyltransferase and mental function in Alzheimer disease. Arch Neurol 1999;56:1121-1123. https://doi.org/10.1001/archneur.56.9.1121
- Kim JM, Shin IS, Yoon JS. Apolipoprotein E among Korean Alzheimer's disease patients in community-dwelling and hospitalized elderly samples. Dement Geriatr Cogn Disord 2002;13:119-124. https://doi.org/10.1159/000048643